Nestorova, R., Rheumatologist
Secretary of the Bulgarian Medical Society for Osteoporosis and Osteoarthritis
NSAIDs are the most widely used drugs in rheumatology practice. Etoricoxib has become popular among the COX-2 inhibitors during the last 15 years. The safety profile of Etoricoxib is reviewed, as well as the rheumatic diseases in which it is most commonly used. The vast number of clinical studies, as well as the practical experience gathered over the years, show that Etoricoxib is the agent of choice in the treatment of rheumatic diseases, due to its proven effectiveness and good safety profile.
Key words: Etoricoxib, Effectiveness, Safety, Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Gout
Address for correspondence:
Nestorova, R.
Rheumatology Centre “St. Irina”
Poligona, Bl. 43
1750, Sofia